37 phenotypes from 2 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Vav2tm1Kdf/Vav2tm1Kdf B6.129S1-Vav2tm1Kdf	abnormal iridocorneal angle	J:158008
	anterior iris synechia	J:158008
	ocular hypertension	J:158008
Vav2tm1Kdf/Vav2tm1Kdf involves: 129S1/Sv * C57BL/6	decreased B cell proliferation	J:69806
	decreased IgG3 level	J:69806
	decreased mature B cell number	J:69806
Vav2tm1Tnr/Vav2tm1Tnr involves: 129P2/OlaHsd	abnormal adrenal gland secretion	J:124056
	abnormal aorta tunica media morphology	J:124056
	abnormal bradykinin level	J:124056
	abnormal class switch recombination	J:69807
	abnormal heart morphology	J:124056
	abnormal physiological response to xenobiotic	J:124056
	adrenal medulla hyperplasia	J:124056
	cardiac fibrosis	J:124056
	decreased B cell number	J:69807
	decreased B cell proliferation	J:69807
	decreased creatinine clearance	J:124056
	decreased IgG1 level	J:69807
	decreased IgG2b level	J:69807
	decreased IgG3 level	J:69807
	decreased IgM level	J:69807
	decreased spleen germinal center number	J:69807
	decreased urine sodium level	J:124056
	enlarged adrenal medulla	J:124056
	heart left ventricle hypertrophy	J:124056
	hydrocephaly	J:124056
	hypertension	J:124056
	increased circulating adrenaline level	J:124056
	increased circulating aldosterone level	J:124056
	increased circulating antidiuretic hormone level	J:124056
	increased circulating noradrenaline level	J:124056
	increased circulating renin level	J:124056
	increased heart rate	J:124056
	increased mean systemic arterial blood pressure	J:124056
	increased myocardial fiber size	J:124056
	increased renin activity	J:124056
	oliguria	J:124056
	renal fibrosis	J:124056
	vascular smooth muscle hyperplasia	J:124056